7 days ago
UNH
AnalystsLance WilkesLance Wilkes's Stock Forecasts
AnalystsLance Wilkes
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4504 out of 5093 analysts
Average Return
-4.82%
Win Rate
35%6 out of 17
Risk vs Reward
Poor
Good
Lance Wilkes's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oak Street Health IncOSH | +81.62% | $19.48 | $35.38 | 2022-05-26 - 2023-02-15 | Buy |
Centene CorpCNC | +24.60% | $28.98 | $36.11 | 2025-09-04 - 2025-11-04 | Buy |
Hca Healthcare IncHCA | +22.67% | $215.55 | $264.41 | 2022-05-26 - 2023-05-26 | Buy |
Humana IncHUM | +21.40% | $243.20 | $295.25 | 2024-10-07 - 2025-10-07 | Buy |
Unitedhealth Group IncUNH | +14.66% | $500.00 | $573.28 | 2023-07-17 - 2024-07-17 | Buy |
Lance Wilkes Analyst Color
Get additional color on Lance Wilkes's coverage of popular stocks
a month ago
UNH
2 months ago
UNH
2 years ago
UNH
3 years ago
CVS
Lance Wilkes's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Unitedhealth Group IncUNH | 6 | Buy | $440.00 | +33.00% | Maintains | 7 days ago |
Molina Healthcare IncMOH | 2 | Buy | $220.00 | +45.03% | Maintains | 2 months ago |
Humana IncHUM | 4 | Buy | $341.00 | +20.98% | Maintains | 2 months ago |
Centene CorpCNC | 3 | Buy | $36.00 | -0.30% | Maintains | 2 months ago |
Cvs Health CorpCVS | 3 | Hold | $77.00 | -1.38% | Maintains | 2 months ago |
Agilon Health IncAGL | 2 | Hold | $1.40 | +93.37% | Downgrades | 3 months ago |
Hca Healthcare IncHCA | 3 | Hold | $301.00 | N/A | Downgrades | 2 years ago |
Cigna GroupCI | 4 | Buy | $372.00 | N/A | Upgrades | 2 years ago |
Oak Street Health IncOSH | 3 | Hold | $39.00 | N/A | Downgrades | 3 years ago |
Elevance Health IncELV | 1 | Buy | $596.00 | N/A | Reinstates | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.